The perfused everted intestinal segment of rat. 1st Communication: Absorption kinetics of markers of different permeation mechanisms

Arzneimittel-Forschung/Drug Research

Volumn 54, Issue 8, 2004, Pages 467-473

  Gandia, Peggy ^a,b   Lacombe, Olivier ^b   Woodley, John ^b   Houin, Georges ^a,b  

^a CHU RANGUEIL   (France)

^b Faculty of Pharmaceutical Sciences   (France)

Author keywords

Everted intestine; P glycoprotein; Paracellular diffusion; Passive diffusion; Permeation; Study of intestinal drug absorption

Indexed keywords

DIGOXIN; GLYCOPROTEIN P; MANNITOL; PHENAZONE;

ACTIVE TRANSPORT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; EX VIVO STUDY; EXPERIMENTAL MODEL; IN VITRO STUDY; INTERCELLULAR SPACE; INTESTINE ABSORPTION; INTESTINE BLOOD FLOW; INTESTINE MOTILITY; INTESTINE MUCOSA PERMEABILITY; ISOLATED ORGAN; MALE; NONHUMAN; RAT; TRANSCYTOSIS; VALIDATION PROCESS;

EID: 4344700106     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1297000     Document Type: Article

References (41)

1. Barthe, L, Woodley, J., Houin, G., Gastrointestinal absorption of drugs: methods and studies. Fundam. Clin. Pharmacol. 13, 154 (1999)
2. Tukker, J. J., In vitro methods for the assessment of permeability. Drugs Pharm. Sci. 106, 51 (2000)
3. Delie, F., Rubas, W., A human colonic cell line sharing similarities with enterocytes as a model to examine oral absorption: advantages and limitations of the Caco-2 model. Crit. Rev. Ther. Drug Carrier Syst. 14, 221 (1997)
4. Boulenc, X., Intestinal cell models, their use in evaluating the metabolism and absorption of xenobiotics. S.T.P. Pharm. Sci. 7, 259 (1997)
5. Artursson, P., Palm, K., Luthman, K, Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv. Drug Deliv. Rev. 22, 67 (1996)
6. Walter, E., Kissel, T., Heterogeneity in the human intestinal cell line Caco-2 leads to differences in the transepithelial transport. Eur. J. Pharm. Sci. 3, 215 (1995)
7. Wilson, T. H., Wiseman, G., The use of sacs of everted small intestine for the study of the transference of substances from the mucosal to the serosal surface. J. Physiol. 123, 116 (1954)
8. Barthe, L., Woodley, J. F., Kenworthy, S. et al., An improved everted gut sac as a simple and accurate technique to measure paracellular transport across the small intestine. Eur. J. Drug Metab. Pharmacokinet. 23, 313 (1998)
9. Barthe, L., Bessouet, M., Woodley, J. F. et al., The improved everted gut sac: a simple method to study intestinal P-glycoprotein. Int. J. Pharm. 173, 255 (1998)
10. Carreno-Gomez, B., Duncan, R., Everted rat intestinal sacs: a new model for the quantitation of P-glycoprotein mediated-efflux of anticancer agents. Anticancer Res. 20, 3157 (2000)
11. Cornaire, G., Woodley, J. F., Saivin, S. et al., Effect of polyoxyl 35 castor oil and polysorbate 80 on the intestinal absorption of digoxin in vitro. Arzneim.-Forsch./Drug Res. 50 (I), 576 (2000)
12. Brown, J. R., Collett, J. H., Attwood, D. et al., Influence of monocaprin on the permeability of a diacidic drug BTA-243 across Caco-2 cell monolayers and everted gut sacs. Int. J. Pharm. 245, 133 (2002)
13. Carreno-Gomez, B., Woodley, J. F., Florence, A. T., Studies on the uptake of tomato lectin nanoparticles in everted gut sacs. Int. J. Pharm. 183, 7 (1999)
14. Woodley, J. F., Levillain, F., Barthe, L. et al., Realistic assessment in vitro of the enhancement of drug absorption by bioadhesive polymers. Proc. Int. Symp. Contr. Rel. Bioact. Mater. 27, Abstract 6205 (2000)
15. Peterson, G. L., Determination of total protein. Meth. Enzymol. 91, 95 (1986)
16. Wandel, C., Kim, R. B., Stein, C. M., "Inactive" excipients such as Cremophor can affect in vivo drug disposition. Clin. Pharmacol. Ther. 73, 394 (2003)
17. Fagerholm, U., Johansson, M., Lennernäs, H., Comparison between permeability coefficients in rat and human jejunum. Pharm. Res. 13, 1336 (1996)
18. Lindahl, A., Sandstrom, R., Ungell, A. L. et al., Concentration and region dependent intestinal permeability of fluvastatin in the rat. J. Pharm. Pharmacol. 50, 737 (1998)
19. Lindahl, A., Krondahl, E., Gruden, A. C. et al., Is the jejunal permeability in rats age-dependent? Pharm. Res. 14, 1278 (1997)
20. Ungell, A. L., Nylander, S., Bergstrand, S. et al., Membrane transport of drugs in different regions of the intestinal tract of the rat. J. Pharm. Sci. 87, 360 (1998)
21. Watanabe, E., Sudo, R., Takahashi, M. et al., Evaluation of absorbability of poorly water-soluble drugs: validity of the use of additives. Biol. Pharm. Bull. 23, 838 (2000)
22. Nellans, H. N., Mechanism of peptide and protein absorption. (1) Paracellular intestinal transport: modulation of absorption. Adv. Drug Deliv. Rev. 7, 339 (1991)
23. Pappenheimer, J. R., Karnovsky, M. L., Maggio, J. E., Absorption and excretion of undegradable peptides: role of lipid solubility and net charge. J. Pharmacol. Exp. Ther. 280, 292 (1997)
24. Pontier, C., Pachot, J., Botham, R. et al., HT29-MTX and Caco-2/TC7 monolayers as predictive models for human intestinal absorption: role of the mucus layer. J. Pharm. Sci. 90, 1608 (2001)
25. Yazdanian, M., Glynn, S. L., Wright, J. L. et al., Correlating partitioning and Caco-2 cell permeability of structurally diverse small molecular weight compounds. Pharm. Res. 15, 1490 (1998)
26. Artursson, P., Ungell, A.-L., Lofroth, J.-E., Selective paracellular permeability in two models of intestinal absorption: cultured layers of human intestinal epithelial cells and rat intestinal segments. Pharm. Res. 10, 1123 (1993)
27. Pantzar, N., Lundin, S., Westrom, B. R., Different properties of the paracellular pathway account for the regional small intestinal permeability to the peptide desmopressin. J. Pharm. Sci. 84, 1245 (1995)
28. Artursson, P., Lindmark, T., Davis, S. S. et al., Effect of chitosan on the permeability of monoloayers of intestinal epithelial cells (Caco-2). Pharm. Res. 11, 1358 (1994)
29. Kotzé, A. F., Wyk, C. J., de Boer, A. G. et al., The effect of chitosan on the paracellular transport pathway. Proc. Int. Symp. Contr. Rel. Bioact. Mater. 23, 425 (1996)
30. Chong, S., Dando, S., Soucek, K. et al., In vitro permeability through Caco-2 cells is not quantitatively predictive of in vivo absorption for peptide-like drugs absorbed via the dipeptide transporter system. Pharm. Res. 13, 120 (1996)
31. Rubas, W., Jezyk, N., Grass, G., Comparison of the permeability characteristics of a human colonic epithelial (Caco-2) cell line to colon of rabbit, monkey, and dog intestine and human drug absorption. Pharm. Res. 10, 113 (1993)
32. Jonker, C., Hamman, J. H., Kotzé, A. F., Intestinal paracellular permeation enhancement with quaternised chitosan: in situ and in vitro evaluation. Int. J. Pharm. 238, 205 (2002)
33. Taipalensuu, J., Tavelin, S., Lazorova, L. et al., Exploring the quantitative relationship between the level of MDR1 transcript, protein and function using digoxin as a marker of MDR1-dependent drug efflux activity. Eur. J. Pharm. Sci. 21, 69 (2004)
34. Chiou, W. L., Chung, S. M., Wu, T. C. et al., A comprehensive account on the role of efflux transporters in the gastrointestinal absorption of 13 commonly used substrate drugs in humans. Int. J. Clin. Pharmacol. Ther. 39, 93 (2001)
35. Cornaire, G., Etudes des effets des excipients pharmaceutiques sur l'absorption des médicaments par l'interaction avec la P-glycoprotéine. Thesis. Université Paul Sabatier, Toulouse (2001)
36. Stephens, R. H., O'Neill, C. A., Warhurst, A. et al., Kinetic profiling of P-glycoprotein-mediated drug efflux in rat and human intestinal epithelia. J. Pharmacol. Exp. Ther. 296, 584 (2001)
37. Stephens, R. H., Tanianis-Hughes, J., Higgs, N. B. et al., Region-dependent modulation of intestinal permeability by drug efflux transporters: in vitro studies in mdr1a(-/-) mouse intestine. J. Pharmacol. Exp. Ther. 303, 1095 (2002)
38. Troutman, M. D., Thakker, D. R., Efflux ratio cannot assess P-glycoprotein-mediated attenuation of absorptive transport: asymmetric effect of P-glycoprotein on absorptive and secretory transport across Caco-2 cell monolayers. Pharm. Res. 20, 1200 (2003)
39. Zhang, S., Morris, M. E., Effect of the flavonoids biochanin A and silymarin on the P-glycoprotein-mediated transport of digoxin and vinblastine in human intestinal Caco-2 cells. Pharm. Res. 20, 1184 (2003)
40. Cornaire, G., Woodley, J. F., Herman, P. et al., Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo. Int. J. Pharm. 278, 119 (2004)
41. Hilgendorf, C., Spahn-Langguth, H., Regãrdh, C. G. et al., Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport. J. Pharm. Sci. 89, 63 (2000)